NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/04/2022
Back to search
Official data from USPTO
THERAPEUTICA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THERAPEUTICA
ST13
US500000076152097Class
20
Filing
76152097
Registration
2619900
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
03/04/2022
Trademark type
Word
Nice classes
20
Filing date
10/23/2000
Registration date
09/17/2002
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/04/2022
Last transaction
03/04/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Foreign priority
First use anywhere
1996-03-00
First use in commerce
1996-07-00
Drawing code
1
Owner type
03
Owner location
OSCEOLA, WI
Examiner
MULLEN, MARK
Law office
M20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
CORE PRODUCTS INTERNATIONAL INC.
THERAPEUTICA INC.
INNOVATIVE CHOICES INC.
Representatives
Scott M. Oldham HAHN LOESER + PARKS LLP
Technical classification
Nice Classes
Class 20
Vienna Codes
No Vienna codes available.
Goods and services
Class 20
pillows
Publications
History of USPTO decisions and trademark events.
32 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
03/04/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/04/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/02/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
10/12/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/17/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/11/2015
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/14/2012
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/14/2012
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/14/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/14/2012
E89R
TEAS SECTION 8 & 9 RECEIVED
08/30/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/25/2008
PLGL
ASSIGNED TO PARALEGAL
06/13/2008
E815
TEAS SECTION 8 & 15 RECEIVED
06/03/2008
CFIT
CASE FILE IN TICRS
12/10/2007
CORV
REVIEW OF CORRESPONDENCE COMPLETE
09/16/2006
CORV
REVIEW OF CORRESPONDENCE COMPLETE
08/15/2006
PAPER RECEIVED
10/07/2004
R.PR
REGISTERED-PRINCIPAL REGISTER
09/17/2002
PUBO
PUBLISHED FOR OPPOSITION
06/25/2002
NPUB
NOTICE OF PUBLICATION
06/05/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/21/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/08/2002
CNSL
LETTER OF SUSPENSION MAILED
12/20/2001
DOCK
ASSIGNED TO EXAMINER
12/20/2001
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
12/20/2001
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/05/2001
DOCK
ASSIGNED TO EXAMINER
11/05/2001
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/23/2001
CNRT
NON-FINAL ACTION MAILED
03/22/2001
DOCK
ASSIGNED TO EXAMINER
03/19/2001
Continuous trademark protection
Get notified about every new filing that threatens THERAPEUTICA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.